ClinicalTrials.Veeva

Menu

Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis (C H R O N O S)

T

Tourcoing Hospital

Status and phase

Completed
Phase 4

Conditions

Diabetes Mellitus

Treatments

Drug: duration of the antibiotic therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02123628
2006-00625-14

Details and patient eligibility

About

The purpose of the study is to compare the efficacy and tolerance of 6- versus 12-week antibiotic therapy in patients with diabetic foot osteomyelitis treated medically.

Full description

The aim of this randomized multicenter clinical study is to compare the efficacy and tolerance of 6 versus 12-week antibiotic treatment in patients with diabetic foot osteomyelitis treated medically as no equivalent data are currenty available in the literature.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diabetic patients treated non-surgically (i.e. without amputation or resection of the infected bone) for an osteomyelitis of the foot complicating a neuropathic foot without ischemia of the foot defined as the absence of any pedal pulse. Patients aged of 18 years or more were included if they had type 2 diabetes and osteomyelitis of the foot (i.e.below the ankle).

Exclusion criteria

  • Patients with gangrene or who require bone resection or amputation when osteomyelitis of the foot was diagnosed

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

antibiotic therapy
Active Comparator group
Description:
patients are treated with a 6 week-duration of antibiotic therapy : * Rifampin IP and PO twice daily, 10mg/kg /12H * Levofloxacin IV and PO 500-750mg once daily * Doxycycline PO 200mg once daily * Trimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily * Fusidic acid PO 500mg twice daily * Linezolid IV and PO 600mg twice daily * Ciprofloxacin IV and PO 750to 1000mg/12h * Cefotaxime IV 100mg/kg in three IV infusions daily * Ceftriaxone IV,intramuscularly or subcutaneously 2g once daily * Cefepime IV ou intra-muscularly 2g /8-12h
Treatment:
Drug: duration of the antibiotic therapy
12 week-duration of antibiotic therapy
Active Comparator group
Description:
patients are treated with a 12 week-duration of antibiotic therapy : * Rifampin IP and PO twice daily, 10mg/kg /12H * Levofloxacin IV and PO 500-750mg once daily * Doxycycline PO 200mg once daily * Trimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily * Fusidic acid PO 500mg twice daily * Linezolid IV and PO 600mg twice daily * Ciprofloxacin IV and PO 750to 1000mg/12h * Cefotaxime IV 100mg/kg in three IV infusions daily * Ceftriaxone IV,intramuscularly or subcutaneously 2g once daily * Cefepime IV ou intra-muscularly 2g /8-12h
Treatment:
Drug: duration of the antibiotic therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems